Zalupski MM - Search Results

1

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.

Bauer TM, El-Rayes BF, Li X, Hammad N, Philip PA, Shields AF, Zalupski MM, Bekaii-Saab T. Bauer TM, et al. Among authors: zalupski mm. Cancer. 2013 Jan 15;119(2):285-92. doi: 10.1002/cncr.27734. Epub 2012 Jul 11. Cancer. 2013. PMID: 22786786 Free PMC article.

2

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

Zalupski M, Metch B, Balcerzak S, Fletcher WS, Chapman R, Bonnet JD, Weiss GR, Ryan J, Benjamin RS, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):926-32. doi: 10.1093/jnci/83.13.926. J Natl Cancer Inst. 1991. PMID: 2067035 Clinical Trial.

3

GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group study.

Hicks LG, Balcerzak SP, Zalupski M. Hicks LG, et al. Cancer Invest. 1996;14(6):507-12. doi: 10.3109/07357909609076895. Cancer Invest. 1996. PMID: 8951354 Clinical Trial.

4

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.

Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.

5

A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.

Philip PA, Zalupski MM, Gadgeel S, Hussain M, Shields A. Philip PA, et al. Among authors: zalupski mm. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-86-S19-88. Semin Oncol. 1997. PMID: 9427274 Clinical Trial.

6

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

7

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Among authors: zalupski mm. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

8

Gemcitabine and UFT plus oral calcium folinate: phase I study.

Philip PA, Ibrahim D, Zalupski M, Arlauskas P, Shields A. Philip PA, et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):116-9. Oncology (Williston Park). 1999. PMID: 10442378 Free article. Clinical Trial.

9

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.

Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH, Fletcher WS, Macdonald JS. Leichman CG, et al. Among authors: zalupski mm. Cancer. 1999 Sep 1;86(5):775-81. Cancer. 1999. PMID: 10463975 Clinical Trial.

10

Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.

Ahmed S, Vaitkevicius VK, Zalupski MM, Du W, Arlauskas P, Gordon C, Kellogg C, Shields AF. Ahmed S, et al. Among authors: zalupski mm. Am J Clin Oncol. 2000 Aug;23(4):420-4. doi: 10.1097/00000421-200008000-00022. Am J Clin Oncol. 2000. PMID: 10955876 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page